What question did this study set out to answer?

This research aims to explore how 6-nitrodopamine affects calcium release and contractility in vascular smooth muscle.

March 21, 2026Open Access

6‐Nitrodopamine Potentiates Catecholamine‐Induced Ca 2+ i Release in Human Aortic Smooth Muscle and Modulates Vascular Smooth Muscle Contractility

Key Result

6-Nitrodopamine enhances catecholamine-driven vasoconstriction and intracellular calcium release in human aortic smooth muscle cells by modulating voltage-gated sodium channels.

Key Points

This research aims to explore how 6-nitrodopamine affects calcium release and contractility in vascular smooth muscle.
Investigated the effects of 6-nitrodopamine on intracellular calcium levels in human aortic smooth muscle cells (HASMCs).
Assessed the impact of 6-nitrodopamine on catecholamine-induced vasoconstriction.
Utilized TTX to determine the involvement of voltage-gated sodium channels.
6-nitrodopamine significantly enhances calcium release in HASMCs during catecholamine stimulation.
Catecholamine-driven vasoconstriction is increased by 6-nitrodopamine.
The effects of 6-nitrodopamine are blocked by TTX, indicating modulation of sodium channels.

Structured PICO

Population

Human Aortic Smooth Muscle Cells (HASMCs)

Intervention

6-Nitrodopamine (6-ND)

Outcome

Modulation of intracellular calcium ([Ca2+]i) and catecholamine-driven vasoconstrictionsurrogate

6-Nitrodopamine acts upstream of calcium entry via voltage-gated sodium channels to potentiate catecholamine-induced vasoconstriction in human aortic smooth muscle.

Main Result

Absolute Event Rate: 0% vs 0%

Abstract

6-ND is a potent modulator of Ca2+i in HASMCs and enhances catecholamine-driven vasoconstriction. Both effects are blocked by TTX, indicating that 6-ND modulates voltage-gated sodium channels upstream of Ca2+ entry/release in vascular smooth muscle cells.